Superworth

National Health Investors revenue NHI

Sales by quarter and over the last twelve months, from 2009.

Last 12 months, to Jun 30, 2026
$432.1M
Latest quarter, Q2 FY26
$121.3M
+34% on a year earlier
Fiscal year 2025
$375.6M
+12% on the year before

National Health Investors' revenue was $432.1M over the twelve months to Jun 30, 2026, up 24% on a year earlier.

In its latest quarter, Q2 FY26, it was $121.3M, up 34% on the same quarter a year before.

Over the five fiscal years to FY2025 it grew 2% a year on average.

Revenue over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearRevenueChange
FY2025$375.6M+12%
FY2024$335.2M+5%
FY2023$319.8M+15%
FY2022$278.2M−7%
FY2021$298.7M−10%
FY2020$332.8M+5%
FY2019$318.1M+8%
FY2018$294.6M+6%
FY2017$278.7M+12%
FY2016$248.5M+9%
FY2015$229M+29%
FY2014$177.5M+51%
FY2013$117.8M+26%
FY2012$93.3M−3%
FY2011$96.2M+23%

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedRevenueOn a year earlierLast 12 months
Q2 FY26$121.3M+34%$432.1M
Q1 FY26$115.1M+29%$401.5M
Q4 FY25$105.8M+23%$375.6M
Q3 FY25$89.8M+8%$355.6M
Q2 FY25$90.7M+7%$348.7M
Q1 FY25$89.3M+10%$343M
Q4 FY24$85.8M+8%$335.2M
Q3 FY24$82.9M+4%$328.9M
Q2 FY24$85M+9%$326.1M
Q1 FY24$81.5M−1%$319M
Q4 FY23$79.5M+12%$319.8M
Q3 FY23$80.1M+5%$311M

Against its peers

Companies in REIT - Specialty nearest National Health Investors' size, closest first, today.

CompanyRevenue, 12 monthsGrowth
NHINational Health Investors$432.1M+24% a year
BNLBroadstone Net Lease$476.2M+8% a year
HIWHighwoods Properties$835.5M+3% a year
IRTIndependence Realty Trust$666.8M+3% a year
LXPLXP Industrial Trust$347.7M−4% a year
CXWCoreCivic$2.5B+24% a year
CDPCopt Defense Properties$784.2M+4% a year
DRHDiamondRock Hospitality$1.1B+1% a year
DXDynex Capitaln/m
HHHHoward Hughes$2.4B+34% a year
AKRAcadia Realty Trustn/m
Peer median$809.9M

Where National Health Investors ranks

What the revenue tells you

Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.

Growing revenue with shrinking margins is a warning, not a win.

More on National Health Investors

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.